Mangoceuticals announces 1-for-15 reverse stock split to meet Nasdaq $1 bid price

MANGOCEUTICALS, INC.

Reverse stock split at 1:15 ratio effective October 16, 2024 at 12:01 a.m. ET.
Outstanding shares reduced from ~35.5M to ~2.4M (subject to fractional rounding).
Split aimed at regaining Nasdaq minimum $1.00 bid price; compliance deadline Oct 28, 2024.
Trading symbol MGRX unchanged; proportional adjustments made to options and warrants.
Authority granted by stockholders in March 2024; final ratio set by Board on Oct 7, 2024.

item 3.03 item 5.03 item 5.07 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.